ReachMD
Be part of the knowledge.™Addressing Gaps to Tackle Obesity in Patients with Type 1 Diabetes
Diabetes DiscourseAddressing Gaps to Tackle Obesity in Patients with Type 1 Diabetes
Anticipated Updates on Statin Intolerance at ACC 2023
ACC Action CenterAnticipated Updates on Statin Intolerance at ACC 2023
Insights from Obesity Canada: A Deep Dive into Guideline Updates
Diabetes DiscourseInsights from Obesity Canada: A Deep Dive into Guideline Updates
Expert Perspectives on Guideline Updates for NASH
GI InsightsExpert Perspectives on Guideline Updates for NASH
Keys to Optimizing LDL Levels in Statin-Intolerant Patients
Heart MattersKeys to Optimizing LDL Levels in Statin-Intolerant Patients
What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
CME/CEWhat You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
Fatty Liver or NASH: The Future of Noninvasive Diagnosis and Assessment
CME/CEFatty Liver or NASH: The Future of Noninvasive Diagnosis and Assessment
Reducing Morbidity and Mortality in Patients with CKD in T2D: New Late-Breaking Data
CME/CEReducing Morbidity and Mortality in Patients with CKD in T2D: New Late-Breaking Data
Beyond A1c: Practical Strategies for Managing Obesity in Patients with T2D
CME/CEBeyond A1c: Practical Strategies for Managing Obesity in Patients with T2D
Rethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Medical Industry FeatureRethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Breaking Down How to Get Adults With Type 2 Diabetes Started
Medical Industry FeatureBreaking Down How to Get Adults With Type 2 Diabetes Started
Key Insights on Early Management of Diabetic Kidney Disease
Medical Industry FeatureKey Insights on Early Management of Diabetic Kidney Disease
The Cardiorenal Connection: Diagnosis & Treatment of CKD Associated with T2D
Medical Industry FeatureThe Cardiorenal Connection: Diagnosis & Treatment of CKD Associated with T2D
Cardiovascular Risk Reduction in Type 2 Diabetes & ASCVD: An Interventional Cardiologist’s Perspective
Heart MattersCardiovascular Risk Reduction in Type 2 Diabetes & ASCVD: An Interventional Cardiologist’s Perspective
CKD in T2D: Exploring Strategies and Tools for Early Risk Assessment
Medical Industry FeatureCKD in T2D: Exploring Strategies and Tools for Early Risk Assessment
medicalxpress.com
09/21/2023- medicalxpress.com
09/21/2023
- thelancet.com
09/20/2023
- scitechdaily.com
09/20/2023
- news.mit.edu
09/20/2023
- medicalxpress.com
09/19/2023